Share-Based Payment Arrangement [Text Block] | Note 12 Stock-based Compensation The Company has three 2006 “2006 2014 “2014 2021 “2021 may no 2006 2014 January 1, 2023, 2021 may three January 1, 2023 December 26, 2021, nine January 1, 2023 December 26, 2021, No January 1, 2023. Stock Options: nine January 1, 2023 December 26, 2021: Nine-Month Periods Ended January 1, 2023 December 26, 2021 Weighted- Weighted- Average Number of Average Number of Exercise Options Exercise Options Price Outstanding Price Outstanding Outstanding at Beginning of Period $ 7.39 635,500 $ 6.84 567,500 Granted 6.54 120,000 7.98 158,000 Exercised 4.92 (20,000 ) 7.72 (70,000 ) Forfeited - - 4.84 (20,000 ) Outstanding at End of Period 7.32 735,500 7.39 635,500 Exercisable at End of Period 7.42 499,000 7.54 352,500 As of January 1, 2023, three January 1, 2023. nine January 1, 2023 not nine January 1, 2023 December 26, 2021. may three December 26, 2021, nine January 1, 2023 December 26, 2021, Stock-based compensation is calculated according to FASB ASC Topic 718, Compensation Stock Compensation nine January 1, 2023 December 26, 2021, two Nine-Month Periods Ended January 1, 2023 December 26, 2021 Number of options issued 120,000 158,000 Grant date June 7, 2022 June 9, 2021 Dividend yield 4.89 % 4.00 % Expected volatility 30.00 % 35.00 % Risk free interest rate 2.95 % 0.53 % Contractual term (years) 10.00 10.00 Expected term (years) 4.00 4.00 Forfeiture rate 5.00 % 5.00 % Exercise price (grant-date closing price) per option $ 6.54 $ 7.98 Fair value per option $ 0.90 $ 1.61 During the three January 1, 2023 December 26, 2021, Three-Month Period Ended January 1, 2023 Three-Month Period Ended December 26, 2021 Cost of Marketing & Cost of Marketing & Products Administrative Total Products Administrative Total Options Granted in Fiscal Year Sold Expenses Expense Sold Expenses Expense 2021 $ - $ 11 $ 11 $ 4 $ 14 $ 18 2022 9 20 29 9 20 29 2023 6 7 13 - - - Total stock option compensation $ 15 $ 38 $ 53 $ 13 $ 34 $ 47 During the nine January 1, 2023 December 26, 2021, Nine-Month Period Ended January 1, 2023 Nine-Month Period Ended December 26, 2021 Cost of Marketing & Cost of Marketing & Products Administrative Total Products Administrative Total Options Granted in Fiscal Year Sold Expenses Expense Sold Expenses Expense 2020 $ - $ - $ - $ 3 $ 4 $ 7 2021 3 37 40 11 37 48 2022 31 66 97 20 52 72 2023 12 17 29 - - - Total stock option compensation $ 46 $ 120 $ 166 $ 34 $ 93 $ 127 As of January 1, 2023, Non-vested Stock Granted to Directors: Number of Shares Fair Value per Share Grant Date Vesting Period (Years) 46,896 $ 6.65 August 16, 2022 One 40,165 7.47 August 11, 2021 One 41,452 5.79 August 12, 2020 Two 46,512 5.16 August 14, 2019 Two The fair value of the non-vested stock granted to the Company’s directors was based on the closing price of the Company’s common stock on the date of each grant. The non-vested stock granted on August 11, 2021 8,033 May 1, 2022, August 2022 August 2021, Non-vested Stock Granted to Employees: Number of Shares Fair Value per Share Grant Date Vesting Date 20,000 $ 4.92 June 10, 2020 June 10, 2022 10,000 7.60 February 22, 2021 February 22, 2023 25,000 7.98 June 9, 2021 June 9, 2022 These shares vest on the dates indicated, assuming continued service. In June 2022, Performance Award Shares: March 1, 2022, ten twenty March 1, 2027; ten twenty March 1, 2027. one third March 1, 2023; ( one third first one third second third During the three nine January 1, 2023 December 26, 2021, Three-Month Periods Ended Nine-Month Periods Ended Stock Granted in Fiscal Year January 1, 2023 December 26, 2021 January 1, 2023 December 26, 2021 2020 $ - $ - $ - $ 40 2021 9 52 76 156 2022 113 125 472 241 2023 78 - 130 - Total stock grant compensation $ 200 $ 177 $ 678 $ 437 As of January 1, 2023, |